Send This Page By E-mail
Print this page

Sidney C. Smith, Jr, MD, FAHA, FACC, FESC

View Faculty Disclosure Statement

Sidney C. Smith, Jr, MD, FAHA, FACC, FESC
Professor of MedicineDirector, Center for Cardiovascular
Science and Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Biographical Sketch

Sidney C. Smith, Jr, MD, FAHA, FACC, FESC, received his medical degree from Yale University in New Haven, Connecticut, and completed a residency in internal medicine and a fellowship in cardiology at Harvard Medical School/Peter Bent Brigham Hospital in Boston, Massachusetts. He is Professor of Medicine and Director of the Center for Cardiovascular Science and Medicine at The University of North Carolina at Chapel Hill.

Dr. Smith served as President of the American Heart Association (AHA) from 1995 to 1996. He served as the first Chief Science Officer of the AHA from 2001 to 2003. Currently, he is Co-Chair of the American College of Cardiology (ACC)/AHA Task Force on Clinical Guidelines. Dr Smith is active on several national committees of the AHA and ACC.

Dr. Smith is a member of the editorial boards of Circulation, Journal of the American College of Cardiology, Journal of Interventional Cardiology, American Heart Journal, and the ACC Education and Learning Program. He also served on the medical advisory board for the Time-Life Medical Series of books. The author of more than 200 articles and book chapters, Dr. Smith presents regularly at scientific meetings and guest lectures. He has spoken about heart disease and stroke in interviews with CNN, CBS, NBC, and many national newspapers.

In 1993, Dr. Smith was honored as the AHA’s Physician of the Year. In 1996, he received the AHA’s Distinguished National Leadership Award and, in 2000, was awarded the AHA’s prestigious Gold Heart Award. In 2003, he received the Eugene Drake Award for his contributions to cardiovascular medicine. Yearly since 1998, he has been elected to Best Doctors in America. Dr. Smith was honored by the National Heart, Lung, and Blood Institute with an award of special recognition in 2003 for his work while serving as Chief Science Officer of the AHA.

The focus of Dr. Smith’s research has been on lipoprotein abnormalities, reperfusion therapies for acute myocardial infarction, and medical management of unstable angina pectoris. He is currently evaluating the role of primary and secondary prevention efforts in the treatment of cardiovascular disease.

Faculty Disclosure Statement

Dr. Smith has disclosed that he has received research support from Merck & Co., Inc. and is a Johnson & Johnson stock shareholder.